Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Japan PM Sanae Takaichi Unveils Growth Plan as BOJ Independence Concerns Lift Bond Yields
Chalco Shares Jump as Chinalco Plans Up to $300 Million Stake Increase
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Asian Stocks Rise as Oil Retreats on Iran Ceasefire Hopes Ahead of Key AI Earnings
Nike Shifts China Online Sales Strategy to Boost Brand and Fight Local Rivals
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Rubio Rejects AI ‘Kill Switch’ Claims as U.S. Defends American Technology Abroad
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Cathay Pacific Sees H1 Profit Surge on Strong Travel Demand
US Stock Futures Rise as AI Optimism Lifts Tech, 3M Jumps on Strong Earnings
Scandinavian Tobacco Group Sells BREAK and Moro Brands to Japan Tobacco for €176 Million
Wistron Opens $700M Texas AI Factory to Build Nvidia Superchips in U.S. 



